Travere Therapeutics Eulerpool News

Travere Therapeutics Eulerpool News

Travere Therapeutics Notizie Azioni

Travere Therapeutics è seguito da molti giornalisti e investitori in tutto il mondo. Qui raccogliamo le più recenti notizie Travere Therapeutics.

• 18 ottobre ·

  GuruFocus
  State Street Corp's Strategic Reduction in Travere Therapeutics Holdings
• 17 ottobre ·

  Yahoo
  Travere Therapeutics and CSL Vifor Announce Swissmedic Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy
• 17 ottobre ·

  Yahoo
  CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
• 17 ottobre ·

  Thefly.com
  Travere Therapeutics, CSL Vifor announce Swissmedic approval of FILSPARI
• 17 ottobre ·

  Thefly.com
  Travere reports Swissmedic grants temporary marketing authorization for Filspari
• 17 ottobre ·

  Benzinga
  12 Health Care Stocks Moving In Thursday's After-Market Session
• 16 ottobre ·

  Benzinga
  Breaking Down Travere Therapeutics: 23 Analysts Share Their Views
• 16 ottobre ·

  Thefly.com
  Disney initiated, Cisco upgraded: Wall Street's top analyst calls
• 16 ottobre ·

  Thefly.com
  Travere Therapeutics initiated with bullish view at Scotiabank, here's why
• 14 ottobre ·

  Yahoo
  Travere Therapeutics to Present Abstracts at American Society of Nephrology (ASN) Kidney Week 2024